Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOEMTECH is a Greek biotechnology company specializing in the design, development, and commercialization of high-performance preclinical molecular imaging systems. The company's flagship "eyes" series includes the γ-eye, β-eye, and X-eye systems, which provide benchtop solutions for PET, SPECT, and X-ray imaging. In addition to hardware, BIOEMTECH operates as a Contract Research Organization (CRO), offering comprehensive preclinical services including radiolabeling, biodistribution studies, and dosimetry. Their expertise bridges the gap between new tracer development and in vivo evaluation, supporting pharmaceutical and academic researchers in drug discovery. The company maintains state-of-the-art laboratories for both biological and isotope research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOEMTECH.